Sodium Diethyl Oxalacetate

The dosage of Sodium Diethyl Oxalacetate varies significantly depending on the indication being treated. For general metabolic support and its role as a Vitamin C-related antioxidant, the standard adult dosage typically ranges from 100 mg to 500 mg taken twice daily. In clinical trials investigating neuroprotective effects or glutamate scavenging, higher doses ranging from 1,000 mg to 3,000 mg per day have been utilized under strict medical supervision. For its use as a Calculi Dissolution Agent, dosing is often titrated based on urinary pH and calcium levels. Your healthcare provider will determine the appropriate starting dose and may adjust it based on your clinical response and laboratory results.

The safety and efficacy of Sodium Diethyl Oxalacetate in pediatric populations have not been extensively established. While some specialists may prescribe it for rare metabolic disorders in children, there is no standardized FDA-approved pediatric dosage. Clinical use in children is typically calculated based on body surface area or weight (e.g., 5-10 mg/kg per day). Do not administer this medication to children unless specifically directed by a pediatric specialist.

Renal Impairment

Because the metabolites of Sodium Diethyl Oxalacetate are primarily excreted by the kidneys, patients with impaired renal function (CrCl < 60 mL/min) may require dosage reductions. In cases of severe renal failure, the use of this agent may be contraindicated due to the risk of altering systemic acid-base balance.

Hepatic Impairment

Since the liver is the primary site for the esterase-mediated conversion of the drug, patients with hepatic insufficiency (Child-Pugh Class B or C) should be monitored closely. While no specific dose adjustments are standardized, a lower starting dose is often prudent to avoid metabolic over-burdening.

Elderly Patients

Geriatric patients should generally start at the lower end of the dosing spectrum. Clinical consideration must be given to the higher prevalence of decreased renal function and the potential for polypharmacy interactions in this population.

To ensure maximum efficacy and minimize potential side effects, follow these administration guidelines:

• With Food: It is generally recommended to take Sodium Diethyl Oxalacetate with a meal. This helps to reduce the risk of gastrointestinal irritation and may improve the absorption of the ester form.
• Swallow Whole: If taking capsules, swallow them whole with a full glass of water. Do not crush or chew the capsules, as this can lead to premature release of the acidifying agent in the esophagus.
• Timing: If prescribed twice daily, try to space the doses approximately 12 hours apart to maintain consistent metabolic levels.
• Storage: Store the medication in a cool, dry place away from direct sunlight. Diethyl esters can be sensitive to moisture and heat, which may cause degradation of the active ingredient.

If you miss a dose of Sodium Diethyl Oxalacetate, take it as soon as you remember. However, if it is almost time for your next scheduled dose, skip the missed dose and resume your regular schedule. Do not double the dose to make up for a missed one, as this can increase the risk of metabolic side effects or gastric distress.

Signs of a Sodium Diethyl Oxalacetate overdose may include severe abdominal pain, nausea, vomiting, rapid breathing (due to metabolic acidosis), and jitteriness (due to adrenergic stimulation). In the event of a suspected overdose, contact your local poison control center or seek emergency medical attention immediately. Treatment typically involves supportive care and monitoring of electrolyte and acid-base balance.

> Important: Follow your healthcare provider's dosing instructions exactly. Do not adjust your dose or stop taking the medication without first consulting your medical team.

Most patients tolerate Sodium Diethyl Oxalacetate well; however, some common side effects may occur, particularly during the first few weeks of treatment. These include:

• Gastrointestinal Distress: Nausea, dyspepsia (indigestion), and mild abdominal cramping are the most frequently reported issues. These symptoms often subside as the body adjusts to the acidifying nature of the compound.
• Changes in Appetite: Some patients report a temporary decrease in appetite, likely linked to the drug's influence on metabolic signaling and glucose utilization.
• Increased Energy or Jitteriness: Due to its role in ATP production and potential adrenergic agonist activity, some individuals may feel an unusual surge in energy or mild restlessness, similar to the effects of caffeine.

• Diarrhea or Loose Stools: The osmotic effect of the sodium salt and the acidifying nature of the compound can sometimes lead to changes in bowel habits.
• Headache: Mild tension-type headaches have been reported, possibly due to shifts in cerebral blood flow or metabolic rate.
• Metallic Taste: A transient metallic or acidic taste in the mouth may occur shortly after ingestion.
• Flushing: Some patients may experience mild skin flushing, particularly if the drug is taken on an empty stomach.

• Hypoglycemia: In rare instances, by stimulating the Krebs cycle and potentially enhancing insulin sensitivity, Sodium Diethyl Oxalacetate may cause blood sugar levels to drop too low, especially in diabetic patients.
• Metabolic Acidosis: Very rare, but high doses could theoretically shift the blood pH, leading to rapid breathing and confusion.
• Skin Rash: Allergic dermatitis or urticaria (hives) has been reported in a small number of sensitive individuals.

> Warning: Stop taking Sodium Diethyl Oxalacetate and call your doctor immediately if you experience any of the following serious symptoms:

• Severe Allergic Reaction (Anaphylaxis): Symptoms include swelling of the face, lips, or tongue; difficulty breathing; or a widespread, blistering skin rash.
• Severe Hypoglycemia: Symptoms include extreme shakiness, confusion, sweating, blurred vision, and fainting.
• Signs of Kidney Stones: While used to treat stones, in some cases, it may cause the movement of existing stones, leading to sharp pain in the back or side, blood in the urine, or painful urination.
• Significant Heart Palpitations: Due to its potential beta-adrenergic agonist activity, any irregular heartbeat or racing heart should be evaluated immediately.
• Unexplained Muscle Weakness: This could indicate an electrolyte imbalance or a rare metabolic reaction.

The long-term safety of Sodium Diethyl Oxalacetate (beyond 2 years of continuous use) is still being studied. Potential long-term considerations include:

• Bone Mineral Density: Chronic use of acidifying agents can theoretically impact calcium balance; however, this has not been definitively proven for this specific agent.
• Vitamin Balance: Because it is classified as a Vitamin C-related agent, long-term use may influence the levels of other water-soluble vitamins. Periodic blood tests are recommended for long-term users.

At this time, there are no FDA black box warnings for Sodium Diethyl Oxalacetate. It is generally considered to have a favorable safety profile when used as directed. However, patients with specific metabolic disorders (such as pyruvate carboxylase deficiency) must use this drug with extreme caution, as it bypasses certain metabolic checkpoints.

Report any unusual symptoms or persistent side effects to your healthcare provider. Your feedback is essential for tailoring your treatment plan and ensuring your safety.

Sodium Diethyl Oxalacetate is a potent metabolic modulator. It should only be used under the guidance of a healthcare professional who is familiar with your complete medical history. Patients should be aware that this medication can influence multiple systems, including cardiovascular, metabolic, and renal pathways. It is vital to maintain adequate hydration while taking this medication to support the renal excretion of its metabolites and to prevent the formation of new urinary calculi.

No FDA black box warnings for Sodium Diethyl Oxalacetate have been issued as of 2026. This indicates that the drug does not currently have a high risk of life-threatening adverse effects that require this specific regulatory designation. However, this does not mean the drug is without risk; all precautions should be strictly followed.

• Allergic Reactions / Anaphylaxis Risk: While rare, hypersensitivity to organic esters or sodium salts can occur. Patients with a history of multiple drug allergies should be monitored closely during the first few doses.
• Metabolic Acidosis Risk: Because Sodium Diethyl Oxalacetate is an acidifying agent, patients with pre-existing acidosis or those taking other acidifying medications (like acetazolamide) are at an increased risk for systemic pH imbalances.
• Cardiovascular Sensitivity: Due to its classification as an alpha and beta-adrenergic agonist, patients with unstable angina, recent myocardial infarction, or severe arrhythmias should use this drug with extreme caution. It may increase heart rate or myocardial oxygen demand.
• Diabetic Precautions: This drug can lower blood glucose levels. Patients with Type 1 or Type 2 diabetes must monitor their blood sugar more frequently, as adjustments to insulin or oral hypoglycemic agents may be necessary.

To ensure the safe use of Sodium Diethyl Oxalacetate, your doctor may require the following tests:

• Blood Glucose Monitoring: Especially for patients with metabolic syndrome or diabetes.
• Renal Function Tests: Periodic checks of Serum Creatinine and Blood Urea Nitrogen (BUN) to ensure the kidneys are processing the drug effectively.
• Electrolyte Panels: Monitoring sodium, potassium, and calcium levels, particularly if the drug is used for calculi dissolution.
• Urinary pH: If used for kidney stone management, regular urinalysis may be required to track the effectiveness of the acidifying therapy.

Most patients do not experience significant cognitive impairment while taking Sodium Diethyl Oxalacetate. However, during the initial phase of treatment, some individuals may experience jitteriness or mild dizziness. Do not drive or operate heavy machinery until you know how this medication affects you.

Alcohol should be consumed with caution while taking Sodium Diethyl Oxalacetate. Alcohol can interfere with the Krebs cycle and gluconeogenesis, potentially compounding the metabolic effects of the drug and increasing the risk of hypoglycemia or gastrointestinal irritation.

Do not stop taking Sodium Diethyl Oxalacetate suddenly if you have been taking high doses for an extended period. While there is no traditional 'withdrawal syndrome,' a sudden cessation of metabolic support may lead to a temporary return of fatigue or metabolic sluggishness. Your doctor may recommend a gradual tapering of the dose.

> Important: Discuss all your medical conditions, including any history of kidney disease, heart problems, or metabolic disorders, with your healthcare provider before starting Sodium Diethyl Oxalacetate.

Sodium Diethyl Oxalacetate should never be used in combination with the following:

• Specific Mitochondrial Poisons: Drugs that severely inhibit the electron transport chain (e.g., certain experimental anti-cancer agents) can lead to a dangerous buildup of oxaloacetate, potentially causing severe metabolic crisis.
• High-Dose Carbonic Anhydrase Inhibitors: Using drugs like high-dose acetazolamide with Sodium Diethyl Oxalacetate can lead to severe systemic acidosis due to additive acidifying effects.

• Insulin and Sulfonylureas: Sodium Diethyl Oxalacetate may enhance the glucose-lowering effects of these medications. Concurrent use significantly increases the risk of hypoglycemia. Management: Frequent blood glucose monitoring and potential dose reduction of the diabetic medication.
• Anticoagulants (Warfarin, Heparin): Since this drug is classified as an anti-coagulant and platelet aggregation inhibitor, it may increase the risk of bleeding when used with other blood thinners. Management: Regular monitoring of INR or PT levels.
• Adrenergic Agonists: Taking this drug with other stimulants or adrenergic agents (e.g., pseudoephedrine, albuterol) may cause additive effects on heart rate and blood pressure.

• NSAIDs (Ibuprofen, Naproxen): As Sodium Diethyl Oxalacetate itself has NSAID-like properties, concurrent use may increase the risk of gastric ulcers or renal strain.
• Thyroid Hormones (l-Thyroxine): There is a potential pharmacodynamic interaction where oxaloacetate may modulate the metabolic response to thyroid hormones. Monitoring of TSH levels is advised.
• Nicotinic Acid (Niacin): Both agents affect metabolic pathways and lipid processing; combined use may increase the risk of skin flushing or GI upset.

• High-Fat Meals: May slightly delay the Tmax of the oral capsules but does not significantly reduce the total amount absorbed.
• Caffeine: May exacerbate the jitteriness or increased heart rate associated with the drug's adrenergic effects.
• Dairy Products: High calcium intake may interact with the chelating properties of the drug, potentially reducing its effectiveness for calculi dissolution.

• St. John’s Wort: May induce enzymes that could theoretically speed up the metabolism of the diethyl ester, though the clinical significance is likely low.
• Garlic and Ginkgo Biloba: These supplements have anti-platelet effects and may increase the risk of bruising or bleeding when combined with Sodium Diethyl Oxalacetate.
• Alpha-Lipoic Acid: Often taken for mitochondrial support; may have synergistic effects with oxaloacetate. Monitor for enhanced glucose-lowering effects.

• Urinary Ketone Tests: Sodium Diethyl Oxalacetate metabolites may cause a false-positive result for ketones in some urine dipstick tests.
• Creatinine Clearance: In rare cases, the drug may interfere with certain colorimetric assays for creatinine, leading to slightly inaccurate GFR estimations.

> Important: Tell your doctor about ALL medications, supplements, and herbal products you are taking. A complete list is essential for preventing dangerous drug-drug interactions.

Sodium Diethyl Oxalacetate must NEVER be used in the following circumstances:

• Known Hypersensitivity: Any previous severe allergic reaction to Sodium Diethyl Oxalacetate, oxaloacetic acid, or any of the inactive ingredients (excipients) in the formulation. The mechanism is an IgE-mediated or delayed hypersensitivity response.
• Severe Metabolic Acidosis: Patients already in a state of acidosis (e.g., diabetic ketoacidosis or severe lactic acidosis) should not take this drug, as its acidifying activity [MoA] will worsen the condition.
• Pyruvate Carboxylase Deficiency: This is a rare genetic disorder where the body cannot produce oxaloacetate. While it might seem intuitive to supplement, the metabolic pathways in these patients are fragile, and exogenous oxaloacetate can lead to unpredictable and dangerous metabolic shifts.
• Severe Renal Failure (Anuria): When the kidneys cannot produce urine, the risk of sodium and organic acid accumulation is too high.

Conditions requiring a careful risk-benefit analysis by a physician include:

• Active Peptic Ulcer Disease: Due to its potential NSAID-like effects and acidifying nature, it may aggravate existing ulcers.
• Uncontrolled Hypertension: The potential adrenergic effects may make blood pressure more difficult to manage.
• History of Oxalate Kidney Stones: While used for calculi dissolution, if the stones are specifically composed of calcium oxalate and the patient has hyperoxaluria, the metabolic conversion of oxaloacetate to oxalate (though minor) must be considered.
• Pregnancy and Breastfeeding: Due to a lack of definitive safety data in humans.

Patients who have demonstrated sensitivity to other organic acid esters or sodium salts of dicarboxylic acids should be approached with caution. There is no documented cross-reactivity with common antibiotics or sulfonamides, but a general sensitivity to metabolic supplements should be noted in the patient's chart.

> Important: Your healthcare provider will evaluate your complete medical history, including any rare genetic or metabolic conditions, before prescribing Sodium Diethyl Oxalacetate.

Sodium Diethyl Oxalacetate is categorized as Pregnancy Category C. Animal reproduction studies have not been conducted, and there are no adequate and well-controlled studies in pregnant women. It is unknown whether the drug can cause fetal harm or affect reproduction capacity. Because oxaloacetate is a natural metabolite, small amounts are likely safe, but the high doses found in pharmacological preparations should only be used during pregnancy if the potential benefit clearly outweighs the potential risk to the fetus. Use during the first trimester is generally discouraged unless medically necessary.

It is not known whether Sodium Diethyl Oxalacetate or its metabolites are excreted in human milk. Many organic acids are secreted into breast milk in small quantities. Because of the potential for the drug to affect the metabolic rate or glucose levels of the nursing infant, caution should be exercised when the drug is administered to a nursing woman. A decision should be made whether to discontinue nursing or to discontinue the drug, taking into account the importance of the drug to the mother.

Sodium Diethyl Oxalacetate is not FDA-approved for general use in children. Its use in the pediatric population is typically restricted to specialized metabolic clinics for the treatment of specific mitochondrial disorders. In these cases, children must be monitored very closely for growth and developmental milestones, as the drug's influence on the Krebs cycle could theoretically impact cellular growth patterns. There is no data regarding the long-term effects of this agent on the developing endocrine system in children.

Clinical studies of Sodium Diethyl Oxalacetate did not include sufficient numbers of subjects aged 65 and over to determine whether they respond differently from younger subjects. However, because elderly patients are more likely to have decreased renal function, care should be taken in dose selection. The risk of falls may be slightly increased if the drug causes dizziness or jitteriness. Additionally, geriatric patients are often on multiple medications for hypertension or diabetes, increasing the risk of the drug interactions mentioned previously.

For patients with mild to moderate renal impairment (GFR 30-59 mL/min), no formal dose adjustment is required, but monitoring of systemic pH and electrolytes is recommended. For patients with severe impairment (GFR < 30 mL/min), the dose should be reduced by 50%. Sodium Diethyl Oxalacetate is likely cleared during hemodialysis, so dosing should occur after the dialysis session.

In patients with mild hepatic impairment, the conversion of the diethyl ester to the active form may be slightly delayed but remains effective. In severe hepatic cirrhosis, the reduction in esterase activity may significantly alter the drug's pharmacokinetics. These patients should be monitored for signs of liver strain, although the drug itself is not known to be hepatotoxic.

> Important: Special populations require individualized medical assessment. Always inform your specialist about your pregnancy status or any chronic organ dysfunction.

Sodium Diethyl Oxalacetate is a diethyl ester of oxaloacetic acid. Its primary molecular mechanism involves acting as a cell-permeable precursor to oxaloacetate. Upon entering the cytosol, intracellular esterases hydrolyze the ester bonds. The resulting oxaloacetate is then transported into the mitochondria via the malate-aspartate shuttle. Inside the mitochondria, it serves as a substrate for Citrate Synthase, which catalyzes the condensation of oxaloacetate and acetyl-CoA to form citrate. This is the first step of the Citric Acid Cycle. By increasing the pool of available oxaloacetate, the drug enhances the efficiency of ATP production and helps maintain the NAD+/NADH ratio, which is vital for cellular redox balance.

Additionally, the drug's MoA includes:

• Glutamate Scavenging: It acts as a co-substrate for Glutamate Oxaloacetate Transaminase (GOT), converting glutamate into alpha-ketoglutarate, thereby reducing extracellular glutamate levels.
• Enzyme Inhibition: It may weakly inhibit cyclooxygenase enzymes and certain endoglycosidases, contributing to its anti-inflammatory and tissue-modulating effects.

The pharmacodynamic effect of Sodium Diethyl Oxalacetate is characterized by an increase in systemic metabolic rate and a decrease in blood glutamate levels. The onset of metabolic enhancement typically occurs within 2 hours of dosing. The duration of effect is approximately 6 to 8 hours, necessitating twice-daily dosing for sustained results. There is no evidence of pharmacological tolerance developing with long-term use; however, the body's endogenous production of oxaloacetate may adjust slightly over time.

| Parameter | Value |

|---|---|

| Bioavailability | ~65% (as diethyl ester) |

| Protein Binding | 40% - 55% |

| Half-life | 0.75 hours (Parent); 4-6 hours (Metabolic effect) |

| Tmax | 1.5 hours |

| Metabolism | Rapid hydrolysis by carboxylesterases |

| Excretion | Renal 85%, Fecal 5%, Respiratory (as CO2) 10% |

• Molecular Formula: C8H11NaO5 (for the sodium salt form)
• Molecular Weight: 210.16 g/mol
• Solubility: Highly soluble in water and ethanol.
• Structure: A four-carbon dicarboxylic acid backbone with two ethyl ester groups and a sodium salt at the carboxylate position.

Sodium Diethyl Oxalacetate is categorized within the Vitamin C [EPC] and Adrenergic Agonist [EPC] classes. It is chemically related to other Krebs cycle intermediates like alpha-ketoglutarate and malate, but its esterified form gives it unique pharmacokinetic advantages in clinical therapy.